Clinical Trial Update: Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4 [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing gemtuzumab ozogamicin plus cytarabine versus idarubicin plus cytarabine in elderly patients with acute myeloid leukemia has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)
• Idarubicin (idarubicin)

Snippet

Sponsor: Versailles Hospital | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED